Covid-19 Vaccine: US government recognises UNICAL alumnus for leading Pfizer research

Reading Time: < 1 minute

The Government of the United States of America has recognised Dr Onyema Ogbuagbu a Nigerian-born doctor, and a 2003-alumnus of the prestigious University of Calabar, UNICAL over his role in the fight against Covid-19 pandemic in the US.

The US Mission in Nigeria on Monday announced a ‘recognition of excellence’ on its social media platforms on favour of Dr Ogbuagbu an Associate Professor of Medicine and Infectious Disease at Yale School of Medicine in respect of his help to develop the first effective Covid-19 vaccine.

Dr Ogbuagbu helped the drug company, Pfizer develop the first ever effective Covid-19 vaccine in the US. He led the Pfizer research for the Covid-19 vaccine. 43,500 persons in six countries have been tested with the vaccine and no safety concerns have been identified. It is said that the vaccine will prevent 90 percent of infection with the virus.

The US Mission described the feat as an ‘incredible contribution to ending this world-wide pandemic’. In a tweet on Monday, the US embassy further commended Ogbuagbu who has years of medical experience for helping ‘the drug company Pfizer develop the first effective COVID-19 vaccine in the United States.

‘Nigerians contribute to the world in so many ways. Our hats off to Dr. Onyema Ogbuagbu at Yale who helped develop a COVID-19 vaccine’.

the controversial Dr. Stella Emmanuel

Recall the controversial Dr. Stella Emmanuel, the Cameroonian physician in the US who asserted Trump was correct that Hydroxychloroquine could cure COVID 19? She is a 1990 alumni from University of Calabar Teaching Hospital in 1990, UCTH.